NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









NZeno

NZeno

Private
AucklandHealthcare & Life Scienceshttps://nzeno.nz/

Last Round

Early Funding

Oct 1, 2023

Total Funding Raised

$2.99M

Company Overview

NZeno is a biotechnology company that develops gene-edited pig-derived products for human xenotransplantation to address the global shortage of organs for kidney transplants.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

xenotransplantationgene-edited organsxenotransplantpig-to-human transplantDPFdesignated pathogen freeorgan shortagebiotechmedical-grade pig tissueCRISPRgene editingend-stage renal diseasepig cloningtransplant research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NZeno Comparables

Compare NZeno with similar companies based on industry and business-model similarity.

NZeno comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Makana Therapeutics
84%
PorMedTec Co., Ltd.
84%
ChoironeX
84%

NZeno Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingOct 1, 2023
SeedJul 1, 2017

Key People

Founding team and executive leadership

Olga Garkavenko

Director Founder, Chief Scientific Officer, Chief Technical Officer

Founding Team

NZeno Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2017

    $2.6M raised from New Zealand Growth Capital Partners and others.

NZeno Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NZeno Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NZeno's valuation, stock price, and market status.

Firmographic Details

HeadquartersAuckland
Employee Range3
Year Founded2016
Last FundingOct 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.